Home > Newsletters > Clinical Trials Advisor > FDA Reorganizes Regulatory Office to Handle Drug Industry Globalization
Clinical Trials Advisor
Sept. 27, 2012 | Vol. 17 No. 19
FDA Reorganizes Regulatory Office to Handle Drug Industry Globalization
The FDA is planning to reorganize its Office of Regulatory Affairs (ORA), including creating new offices and reorganizing others, as it takes steps to dissolve cumbersome domestic and international distinctions and to keep up with increasingly global operations.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.